Qube Research & Technologies LTD Omega Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.81 - $10.95 $74,175 - $168,859	15,421 Added 72.33%	36,742 $221,000
Q4 2022 Feb 14, 2023	BUY	$4.22 - $7.05 $40,946 - $68,406	9,703 Added 83.52%	21,321 $121,000
Q3 2022 Nov 14, 2022	SELL	$3.63 - $6.65 $7,263 - $13,306	-2,001 Reduced 14.69%	11,618 $63,000
Q2 2022 Aug 15, 2022	BUY	$2.01 - $7.19 $27,374 - $97,920	13,619 New	13,619 $52,000

43.4M

25.8K

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $27.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.